Back to Research Hub
Alvotech
ALVO
$4.16-0.08 (-1.89%)
Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer.
StreetsValue research for Alvotech (ALVO)
Members get the full report for Alvotech: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.